UroGen Pharma Ltd.

NasdaqGM:URGN Stock Report

Mkt Cap: US$197.7m

UroGen Pharma Management

How experienced are the management team and are they aligned to shareholders interests?

2.8yrs

Average management tenure

CEO

Liz Barrett (60 yo)

4yrs

Tenure

US$4,365,748

Compensation

Ms. Elizabeth A. Barrett, also known as Liz, has been President, Chief Executive Officer and Director of UroGen Pharma Ltd. since January 3, 2019. She has been a Director at Allogene Therapeutics, Inc. sin...

CEO Compensation Analysis

How has Liz Barrett's remuneration changed compared to UroGen Pharma's earnings?
DateTotal Comp.SalaryCompany Earnings
Sep 30 2022n/an/a

-US$109m

Jun 30 2022n/an/a

-US$114m

Mar 31 2022n/an/a

-US$113m

Dec 31 2021US$4mUS$739k

-US$111m

Sep 30 2021n/an/a

-US$113m

Jun 30 2021n/an/a

-US$111m

Mar 31 2021n/an/a

-US$117m

Dec 31 2020US$2mUS$637k

-US$128m

Sep 30 2020n/an/a

-US$137m

Jun 30 2020n/an/a

-US$130m

Mar 31 2020n/an/a

-US$121m

Dec 31 2019US$26mUS$695k

-US$105m

Compensation vs Market: Liz's total compensation ($USD4.37M) is above average for companies of similar size in the US market ($USD1.65M).

Compensation vs Earnings: Liz's compensation has increased whilst the company is unprofitable.

Leadership Team

NamePositionTenureCompensationOwnership
Elizabeth Barrett
President4yrsUS$4.37m1.34%
$ 2.6m
Jason Smith
General Counsel2.42yrsUS$968.27k0.053%
$ 104.2k
Mark Schoenberg
Chief Medical Officer5.08yrsUS$1.02m0.10%
$ 205.0k
Dong Kim
Chief Financial Officer0.83yrno data0.14%
$ 273.2k
Vincent Perrone
Senior Director of Investor Relationsno datano datano data
Eric Van Zanten
Senior Director of Communicationsno datano datano data
Sari Prutchi-Sagiv
Marketing Directorno datano datano data
Marina Konorty
Executive Vice President of Research & Development and Technical Operations2.83yrsno datano data
Jeffrey Bova
Chief Commercial Officer2.83yrsno datano data
James Ottinger
Executive Vice President of Regulatory Affairs & Quality2.83yrsno datano data
Polly Murphy
Chief Business Officer2.33yrsno datano data
Gil Hakim
Consultant4.42yrsUS$3.86mno data

2.8yrs

Average Tenure

55yo

Average Age

Experienced Management: URGN's management team is considered experienced (2.8 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Elizabeth Barrett
President4yrsUS$4.37m1.34%
$ 2.6m
Fred Cohen
Independent Director5.67yrsUS$192.69k0.065%
$ 128.4k
Cynthia Butitta
Independent Director5.25yrsUS$205.19k0%
$ 0
Stuart Holden
Independent Director7.08yrsUS$195.19k0%
$ 0
Arie Belldegrun
Independent Chairman10.08yrsUS$342.69k1.77%
$ 3.5m
Dan Wildman
Director0.17yrno datano data
Ran Nussbaum
Independent Director9.67yrsUS$187.69kno data
Jack Baniel
Member of Scientific Advisory Boardno datano datano data
Herbert Lepor
Chairman of Scientific Advisory Boardno datano datano data
Fred Witjes
Member of Scientific Advisory Boardno datano datano data
Leana Wen
Director0.33yrno datano data

5.5yrs

Average Tenure

66yo

Average Age

Experienced Board: URGN's board of directors are considered experienced (5.5 years average tenure).